Literature DB >> 28905392

Cryopreserved platelets demonstrate reduced activation responses and impaired signaling after agonist stimulation.

Lauren Waters1, Matthew P Padula2, Denese C Marks1, Lacey Johnson1.   

Abstract

BACKGROUND: Room temperature-stored (20-24°C) platelets (PLTs) have a shelf life of 5 days, making it logistically challenging to supply remote medical centers with PLT products. Cryopreservation of PLTs in dimethyl sulfoxide (DMSO) and storage at -80°C enables an extended shelf life up to 2 years. Although cryopreserved PLTs have been widely characterized under resting conditions, their ability to undergo agonist-induced activation is yet to be fully explored. STUDY DESIGN AND METHODS: Buffy coat PLTs were cryopreserved at -80°C with 5% to 6% DMSO and sampled before freezing and after thawing. PLTs were analyzed under resting conditions and after agonist stimulation with adenosine diphosphate, collagen, or thrombin receptor-activating peptide-6. The expression of activation markers, microparticle formation, and calcium mobilization were analyzed by flow cytometry. Soluble PLT proteins present in the PLT supernatant were examined by enzyme-linked immunosorbent assay. Protein phosphorylation was investigated with Western blotting.
RESULTS: After cryopreservation, PLTs displayed increased surface activation markers and higher basal calcium levels. Cryopreserved PLTs demonstrated diminished aggregation responses. Additionally, cryopreserved PLTs showed a limited ability to become activated (as measured by CD62P and phosphatidylserine exposure and cytokine release) after agonist stimulation. A reduction in the abundance and phosphorylation of key signaling proteins (Akt, Src, Lyn, ERK, and p38) was seen in cryopreserved PLTs.
CONCLUSIONS: Cryopreservation of PLTs induces dramatic changes to the basal PLT phenotype and renders them largely nonresponsive to agonist stimulation, likely due to the alterations in signal transduction. Therefore, further efforts are required to understand how cryopreserved PLTs achieve their hemostatic effect once transfused.
© 2017 AABB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28905392     DOI: 10.1111/trf.14310

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.

Authors:  Nahreen Tynngård; Agneta Wikman; Michael Uhlin; Per Sandgren
Journal:  Blood Transfus       Date:  2019-07-04       Impact factor: 3.443

Review 2.  Platelet Biochemistry and Morphology after Cryopreservation.

Authors:  Katrijn R Six; Veerle Compernolle; Hendrik B Feys
Journal:  Int J Mol Sci       Date:  2020-01-31       Impact factor: 5.923

3.  Impact of cold storage on platelets treated with Intercept pathogen inactivation.

Authors:  Katrijn R Six; Rosalie Devloo; Veerle Compernolle; Hendrik B Feys
Journal:  Transfusion       Date:  2019-06-12       Impact factor: 3.337

4.  Cryopreservation of buffy coat derived platelets: Paired in vitro characterization using uncontrolled versus controlled freezing rate protocols.

Authors:  Nahreen Tynngård; Alice Bell; Gunilla Gryfelt; Stefan Cvetkovic; Agneta Wikman; Michael Uhlin; Per Sandgren
Journal:  Transfusion       Date:  2020-12-21       Impact factor: 3.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.